Literature DB >> 3665086

Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis.

D W Howells1, K Hyland.   

Abstract

Measurement of tetrahydrobiopterin in cerebrospinal fluid requires careful handling of samples during storage and analysis. Addition of dithioerythritol and deoxygenation of the mobile phase with helium prevents breakdown of tetrahydrobiopterin during chromatography. Tetrahydrobiopterin in cerebrospinal fluid is unstable at room temperature, 100% being lost within 3.5 h, this breakdown does not generate equivalent quantities of dihydrobiopterin and biopterin. Addition of dithioerythritol and diethylenetriaminepenta-acetic acid to cerebrospinal fluid prevents breakdown of tetrahydrobiopterin for 6 mth at -70 degrees C and for up to 5 h at 4 degrees C. At room temperature less than 5% of tetrahydrobiopterin was lost after 2 h.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3665086     DOI: 10.1016/0009-8981(87)90081-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  Aromatic amino acid decarboxylase deficiency in twins.

Authors:  K Hyland; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Tetrahydrobiopterin and quinonoid dihydrobiopterin concentrations in CSF from patients with dihydropteridine reductase deficiency.

Authors:  K Hyland; S J Heales
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  The N-terminal peptide of mammalian GTP cyclohydrolase I is an autoinhibitory control element and contributes to binding the allosteric regulatory protein GFRP.

Authors:  Christina E Higgins; Steven S Gross
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

4.  Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Authors:  Bert K Lopansri; Nicholas M Anstey; Gregory J Stoddard; Esther D Mwaikambo; Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Maurine R Hobbs; Marc C Levesque; J Brice Weinberg; Donald L Granger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.

Authors:  J A Vita; B Frei; M Holbrook; N Gokce; C Leaf; J F Keaney
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.

Authors:  Tomas Björklund; Thomas Carlsson; Erik Ahlm Cederfjäll; Manolo Carta; Deniz Kirik
Journal:  Brain       Date:  2010-02-02       Impact factor: 13.501

Review 7.  Physiology and pathophysiology of organic acids in cerebrospinal fluid.

Authors:  G F Hoffmann; W Meier-Augenstein; S Stöckler; R Surtees; D Rating; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 8.  Abnormalities of biogenic amine metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Modification of the endogenous NO level influences apple embryos dormancy by alterations of nitrated and biotinylated protein patterns.

Authors:  Urszula Krasuska; Katarzyna Ciacka; Sławomir Orzechowski; Joerg Fettke; Renata Bogatek; Agnieszka Gniazdowska
Journal:  Planta       Date:  2016-06-14       Impact factor: 4.116

10.  Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.

Authors:  Erik Cederfjäll; Gurdal Sahin; Deniz Kirik; Tomas Björklund
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.